154 related articles for article (PubMed ID: 31707599)
1. Evaluation of the relationship between the IL-17A gene expression level and regulatory miRNA-9 in relation to tumor progression in patients with non-small cell lung cancer: a pilot study.
Migdalska-Sęk M; Góralska K; Jabłoński S; Kordiak J; Nawrot E; Kiszałkiewicz JM; Pastuszak-Lewandoska D; Baran K; Stuss M; Brzeziańska-Lasota E
Mol Biol Rep; 2020 Jan; 47(1):583-592. PubMed ID: 31707599
[TBL] [Abstract][Full Text] [Related]
2. Interleukin 17A polymorphism elevates gene expression and is associated with increased risk of nonsmall cell lung cancer.
Cheng S; Shao Z; Liu X; Guo L; Zhang X; Na Q; Chen X; Ma Y; Zheng J; Song B; Liu J
DNA Cell Biol; 2015 Jan; 34(1):63-8. PubMed ID: 25289477
[TBL] [Abstract][Full Text] [Related]
3. Potential Impacts of
Lee KL; Lai TC; Wang YC; Shih PC; Yang YC; Tsao TC; Liu TC; Wen YC; Chang LC; Yang SF; Chien MH
Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33802737
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-187-5p suppresses cancer cell progression in non-small cell lung cancer (NSCLC) through down-regulation of CYP1B1.
Mao M; Wu Z; Chen J
Biochem Biophys Res Commun; 2016 Sep; 478(2):649-55. PubMed ID: 27495872
[TBL] [Abstract][Full Text] [Related]
5. Expression analysis of three miRNAs, miR-26a, miR-29b and miR-519d, in relation to MMP-2 expression level in non-small cell lung cancer patients: a pilot study.
Pastuszak-Lewandoska D; Kordiak J; Czarnecka KH; Migdalska-Sęk M; Nawrot E; Domańska-Senderowska D; Kiszałkiewicz JM; Antczak A; Górski P; Brzeziańska-Lasota E
Med Oncol; 2016 Aug; 33(8):96. PubMed ID: 27447710
[TBL] [Abstract][Full Text] [Related]
6. IL-17A/IL-17RA promotes invasion and activates MMP-2 and MMP-9 expression via p38 MAPK signaling pathway in non-small cell lung cancer.
Wu Z; He D; Zhao S; Wang H
Mol Cell Biochem; 2019 May; 455(1-2):195-206. PubMed ID: 30564960
[TBL] [Abstract][Full Text] [Related]
7. [Expression of microRNA let-7a, miR-155, and miR-205 in tumor and tumor-adjacent histologically normal tissue in patients with non-small cell lung cancer].
Shikeeva AA; Kekeeva TV; Zavalishina LE; Andreeva YY; Zaletaev DV; Frank GA
Arkh Patol; 2016; 78(3):3-10. PubMed ID: 27296000
[TBL] [Abstract][Full Text] [Related]
8. The Expression Levels of IL-4/IL-13/STAT6 Signaling Pathway Genes and SOCS3 Could Help to Differentiate the Histopathological Subtypes of Non-Small Cell Lung Carcinoma.
Pastuszak-Lewandoska D; Domańska-Senderowska D; Antczak A; Kordiak J; Górski P; Czarnecka KH; Migdalska-Sęk M; Nawrot E; Kiszałkiewicz JM; Brzeziańska-Lasota E
Mol Diagn Ther; 2018 Oct; 22(5):621-629. PubMed ID: 30105735
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomic studies provide insights into the tumor suppressive role of miR-146a-5p in non-small cell lung cancer (NSCLC) cells.
Iacona JR; Monteleone NJ; Lemenze AD; Cornett AL; Lutz CS
RNA Biol; 2019 Dec; 16(12):1721-1732. PubMed ID: 31425002
[TBL] [Abstract][Full Text] [Related]
10. MiR-541-3p reverses cancer progression by directly targeting TGIF2 in non-small cell lung cancer.
Lu YJ; Liu RY; Hu K; Wang Y
Tumour Biol; 2016 Sep; 37(9):12685-12695. PubMed ID: 27448300
[TBL] [Abstract][Full Text] [Related]
11. Expression of miRNAs in non-small-cell lung carcinomas and their association with clinicopathological features.
Tafsiri E; Darbouy M; Shadmehr MB; Zagryazhskaya A; Alizadeh J; Karimipoor M
Tumour Biol; 2015 Mar; 36(3):1603-12. PubMed ID: 25384507
[TBL] [Abstract][Full Text] [Related]
12. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
Zhou Y; Li S; Li J; Wang D; Li Q
Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
[TBL] [Abstract][Full Text] [Related]
13. [Methylation of some miRNA genes is involved in the regulation of their target genes RAR-beta2 and NKIRAS1 expression in lung cancer].
Khodyrev DS; Pronina IV; Rykov SV; Beresneva EV; Fridman MV; Kazubskaia TP; Loginov VI; Braga ÉA
Mol Biol (Mosk); 2012; 46(5):773-85. PubMed ID: 23156677
[TBL] [Abstract][Full Text] [Related]
14. MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip.
Gao L; Yan SB; Yang J; Kong JL; Shi K; Ma FC; Huang LZ; Luo J; Yin SY; He RQ; Hu XH; Chen G
BMC Med Genomics; 2020 Jan; 13(1):3. PubMed ID: 31906958
[TBL] [Abstract][Full Text] [Related]
15. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
Zheng J; Xu T; Chen F; Zhang Y
Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
[TBL] [Abstract][Full Text] [Related]
16. Correlation between microRNA expression, clinicopathological characteristics, and prognosis in patients with Non-small cell Lung Cancer: A retrospective study.
Wang X; Zhang Y; Zhi X
Thorac Cancer; 2017 Sep; 8(5):511-516. PubMed ID: 28727276
[TBL] [Abstract][Full Text] [Related]
17. Expression of IL-17A, E, and F and their receptors in non-small-cell lung cancer.
Huang Q; Ma XC; Yang X; Wang W; Li Y; Lv Z; Corrigan CJ; Chen Y; Ying S
J Biol Regul Homeost Agents; 2018; 32(5):1105-1116. PubMed ID: 30334403
[TBL] [Abstract][Full Text] [Related]
18. miR-196b-5p-mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer.
Liang G; Meng W; Huang X; Zhu W; Yin C; Wang C; Fassan M; Yu Y; Kudo M; Xiao S; Zhao C; Zou P; Wang Y; Li X; Croce CM; Cui R
Proc Natl Acad Sci U S A; 2020 Feb; 117(8):4347-4357. PubMed ID: 32041891
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 17A genetic variations and susceptibility to non-small cell lung cancer.
Ma QY; Chen J; Wang SH; Wu N; Hao ZH; Chen XF
APMIS; 2015 Mar; 123(3):194-8. PubMed ID: 25469655
[TBL] [Abstract][Full Text] [Related]
20. Long-term PM
Chao X; Yi L; Lan LL; Wei HY; Wei D
Aging (Albany NY); 2020 Jun; 12(12):11579-11602. PubMed ID: 32554855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
